文献速递哮喘

重症哮喘病理生理学:研究刚刚起步

Pathophysiology of severe asthma: We've only just started.
PubMed 文献 · Respirology · 2018-01-09

重症哮喘以需高治疗需求部分或完全控制临床表现为定义,全球范围内对个体和卫生服务造成巨大负担。本综述聚焦重症哮喘相关的结构、力学和炎症异常,指出认识其病理生理和机制是改善靶向治疗、减轻疾病负担和改善患者结局的关键。

要点

  • 重症哮喘需高治疗需求才能部分或完全控制临床表现。
  • 认识结构、力学和炎症异常是改善靶向治疗的关键。
  • 重症哮喘的异质性、复杂性和临床研究困难仍是挑战。

核心结论

  • 更好理解重症哮喘的病理生理和机制是改善靶向治疗、减轻疾病负担和改善患者结局的关键。

研究设计与样本

  • 综述,聚焦重症哮喘相关的结构、力学和炎症异常。

主要发现

  • 重症哮喘的异质性、复杂性和临床研究困难仍是获得更好理解和更好结局的挑战。

局限性

  • 重症哮喘的异质性、复杂性和临床研究困难仍是挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Severe asthma is defined by the high treatment requirements to partly or fully control the clinical manifestations of disease. It remains a problem worldwide with a large burden for individuals and health services. The key to improving targeted treatments, reducing disease burden and improving patient outcomes is a better understanding of the pathophysiology and mechanisms of severe disease. The heterogeneity, complexity and difficulties in undertaking clinical studies in severe asthma remain challenges to achieving better understanding and better outcomes. In this review, we focus on the structural, mechanical and inflammatory abnormalities that are relevant in severe asthma.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. King GG, James A, Harkness L, et al. Pathophysiology of severe asthma: We've only just started. Respirology. 2018. PMID: 29316003. doi:10.1111/resp.13251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。